Less than one month away from OneMedForumNY 2013, June 26-27 in New York City. We are excited to announce our preliminary presenting company schedule. You can view this list here.
Our Sentinel this week features the second installment of our series on bioinformatics. Bioinformatics has become an essential catalyst to better understanding gene therapy, as well as a unique investment opportunity.
In addition, OneMedRadio spoke with Cyto Wave Therapeutics head George Yu, discussing in vivo testing for CTCs. Lastly, don’t miss our feature exploring the state of influenza, and alternatives to traditional vaccination being developed by NanoViricides (NNVC).
Enjoy this issue.
About the Author
Through our news, radio interviews, video production, and research, OneMedPlace specializes in delivering information to investors covering nanocap, microcap and private emerging growth companies in the hottest areas of life sciences. OneMedPlace covers what we believe to be an undervalued sector, and has built a network of investors at all levels of financial and strategic development. OneMedPlace produces two investor conferences, OneMedForumSF in January and OneMedForumNY in June, bringing together our diverse network to meet the most promising companies in life sciences. Visit our website to learn more about attending.